The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
mono-(2-ethylhexyl)phthalate results in decreased expression of ACSL4 mRNA ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein] mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein
mono-(2-ethylhexyl)phthalate results in increased expression of AHR mRNA mono-(2-ethylhexyl)phthalate affects the expression of AHR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of AHR mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of AHRR mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of AIFM1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of AIFM1 mRNA; Estradiol affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of AIFM1 mRNA]
AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA]; AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein]; AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFKB1 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased expression of and results in increased phosphorylation of AKT1 protein] AKT1 protein affects the susceptibility to mono-(2-ethylhexyl)phthalate mono-(2-ethylhexyl)phthalate results in increased activity of AKT1 protein mono-(2-ethylhexyl)phthalate results in increased phosphorylation of AKT1 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein] [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of AKT1 protein; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of AKT1 protein]
mono-(2-ethylhexyl)phthalate analog results in decreased expression of ALPL protein; mono-(2-ethylhexyl)phthalate results in decreased expression of ALPL protein
mono-(2-ethylhexyl)phthalate results in decreased expression of ANTXR2 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ANTXR2 mRNA
mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in increased expression of AR] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of AR mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ARNT mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ARNT mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of ARNT protein
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ATF6 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of ATP1A3 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of ATP1A3 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of BAX mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of BAX protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BAX protein]; GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BAX protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BAX mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein [mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of BCL2 mRNA; epigallocatechin gallate affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of BCL2 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BCL2 mRNA; MIR16-1 mRNA affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein]
AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA]; AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BCL2L10 mRNA; Estradiol affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2L10 mRNA]
mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L11 protein]
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of BID mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of BOK mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of BOK mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP1 protein]
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CASP3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased cleavage of CASP3 protein; PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]; Rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]] mono-(2-ethylhexyl)phthalate results in increased expression of CASP3 protein mono-(2-ethylhexyl)phthalate results in increased cleavage of CASP3 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP3 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CASP8 mRNA; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CASP8 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CASP8 mRNA
Cycloheximide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of CAT protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA mono-(2-ethylhexyl)phthalate results in increased activity of CAT protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CAT mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNA2 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNB1 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNB2 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCND3 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CCNE1 mRNA
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CCR7 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of CD163 protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in decreased expression of CD163 mRNA mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD163 mRNA]
mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD36 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of CD36 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CD36 mRNA
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and affects the localization of CDH2 protein
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDK2 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDK4 mRNA; Estradiol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CDK4 mRNA]
mono-(2-ethylhexyl)phthalate results in decreased expression of CDKN1A mRNA mono-(2-ethylhexyl)phthalate results in increased expression of CDKN1A protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN1A mRNA Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CDKN1A protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CDKN1A protein]
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1C mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2A mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2A mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CDKN2B mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2C mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of CDKN2D mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] mono-(2-ethylhexyl)phthalate results in increased expression of CEBPA mRNA
[IC 261 results in decreased activity of CSNK1A1 protein] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CELSR2 protein] mono-(2-ethylhexyl)phthalate affects the transport of CELSR2 protein
mono-(2-ethylhexyl)phthalate inhibits the reaction [CGA protein results in increased abundance of Estradiol] mono-(2-ethylhexyl)phthalate affects the expression of CGA mRNA mono-(2-ethylhexyl)phthalate results in increased expression of CGA mRNA mono-(2-ethylhexyl)phthalate results in increased secretion of CGA protein mono-(2-ethylhexyl)phthalate inhibits the reaction [CGA protein results in increased abundance of Progesterone]
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CHEK2 protein gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CHEK2 protein]
[IC 261 results in decreased activity of CSNK1A1 protein] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of CELSR2 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of CTNNB1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and affects the localization of CTNNB1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of CXCL10 mRNA [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA
mono-(2-ethylhexyl)phthalate results in increased activity of CYP11A1 protein mono-(2-ethylhexyl)phthalate results in increased expression of CYP11A1 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of CYP11A1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP11A1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CYP11A1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of CYP11A1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of CYP17A1 mRNA mono-(2-ethylhexyl)phthalate affects the expression of CYP17A1 mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of CYP17A1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP17A1 mRNA
mono-(2-ethylhexyl)phthalate results in decreased activity of CYP19A1 protein mono-(2-ethylhexyl)phthalate inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA alitretinoin promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP19A1 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of CYP19A1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP19A1 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of CYP1A1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of CYP1A1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of CYP1A1 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of CYP1B1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CYP1B1 mRNA]; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CYP1B1 mRNA
mono-(2-ethylhexyl)phthalate results in decreased activity of CYP2C11 protein CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate; CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of 2-ethyl-5-carboxypentyl phthalate; [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP2C9 protein polymorphism results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid; [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP2C9 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate
CYP2C6V1 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate [CYP2C19 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP2C19 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate [CYP2C6V1 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP2C6V1 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP2C6V1 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid
CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP3A4 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid; [Dexamethasone co-treated with mono-(2-ethylhexyl)phthalate] results in increased activity of CYP3A4 protein mono-(2-ethylhexyl)phthalate results in increased expression of CYP3A4 mRNA [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-hydroxyhexyl) phthalate; [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of mono(2-ethyl-5-oxohexyl)phthalate; [CYP3A2 protein results in increased metabolism of mono-(2-ethylhexyl)phthalate] which results in increased chemical synthesis of phthalic acid
mono-(2-ethylhexyl)phthalate results in increased expression of DDIT3 mRNA 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of DDIT3 protein] arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of DDIT3 protein] mono-(2-ethylhexyl)phthalate affects the expression of DDIT3 protein
mono-(2-ethylhexyl)phthalate affects the expression of DHCR7; mono-(2-ethylhexyl)phthalate affects the expression of DHCR7 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of DHCR7 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of DIABLO mRNA mono-(2-ethylhexyl)phthalate results in increased expression of DIABLO protein
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DICER1 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of DLL4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of DLL4 protein
mono-(2-ethylhexyl)phthalate results in increased expression of DNMT1 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of DNMT1 mRNA; [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DNMT1 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of DROSHA mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN1 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN3 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of EGLN3 protein
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2A protein arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2A protein]
mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein; mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein modified form mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein]; 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of EIF2AK3 protein] 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of EIF2AK3 protein modified form]; mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of EIF2AK3 protein modified form]
mono-(2-ethylhexyl)phthalate results in increased expression of ERN1 protein; mono-(2-ethylhexyl)phthalate results in increased expression of ERN1 protein modified form mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of ERN1 protein]
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ERO1A protein]
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of ESR1 mRNA; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of ESR1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of ESR1 mRNA; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of ESR1 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP2 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP9 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 mRNA]; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of ESR1 protein mono-(2-ethylhexyl)phthalate results in increased expression of ESR1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of ESR1 protein
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of ESR2 mRNA mono-(2-ethylhexyl)phthalate binds to and results in increased activity of ESR2 protein
mono-(2-ethylhexyl)phthalate results in increased expression of FABP3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FABP3 protein
mono-(2-ethylhexyl)phthalate analog results in increased expression of FABP4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 protein T 0070907 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FABP4 mRNA]
FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate [FASL affects the susceptibility to mono-(2-ethylhexyl)phthalate] which affects the expression of CFLAR protein
mono-(2-ethylhexyl)phthalate results in increased expression of FASN mRNA mono-(2-ethylhexyl)phthalate results in increased expression of FASN protein [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of FASN mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of FASN mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA mono-(2-ethylhexyl)phthalate results in increased secretion of FGF21 protein alpha-cyano-4-hydroxycinnamate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]; PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]; PPARA inhibits the reaction [PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]]
mono-(2-ethylhexyl)phthalate results in increased expression of FOS mRNA mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS protein]
mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of FOXO1 protein Genistein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of FOXO1 mRNA] [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of FOXO1 mRNA
mono-(2-ethylhexyl)phthalate inhibits the reaction [FSHB protein results in increased abundance of Estradiol] mono-(2-ethylhexyl)phthalate results in increased expression of FSHB protein mono-(2-ethylhexyl)phthalate results in decreased expression of FSHB mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of FSHR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of FSHR mRNA
ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein
mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased expression of FOS protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK1 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK3 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein]
mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of GPX1 mRNA; Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of GPX1 protein] mono-(2-ethylhexyl)phthalate results in decreased expression of GPX1 mRNA
ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein] mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein
mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein] mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of GSK3B protein [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of GSK3B protein]
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of GSR mRNA
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HDAC6 protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK1 protein]; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK3 protein]; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN protein]; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein]; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of AKT1 protein]; tubastatin A inhibits the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HDAC6 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of HIF1A mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of HIF1A protein HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GPX4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of ACSL4 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FTH1 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [HIF1A protein binds to HMOX1 promoter]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased stability of and affects the localization of HIF1A protein HIF1A gene mutant form results in decreased susceptibility to mono-(2-ethylhexyl)phthalate
mono-(2-ethylhexyl)phthalate results in increased expression of HMGCR mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of HMGCR mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of HMGCS1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of HMGCS1 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of HMOX1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [HIF1A protein binds to HMOX1 promoter]
mono-(2-ethylhexyl)phthalate results in decreased activity of HSD11B2 protein mono-(2-ethylhexyl)phthalate results in decreased expression of HSD11B2 mRNA mono-(2-ethylhexyl)phthalate affects the expression of HSD11B2 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD17B1 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of HSD3B1 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of HSPA5 protein 7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of GRP78 protein]; arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of GRP78 protein] mono-(2-ethylhexyl)phthalate inhibits the reaction [4-phenylbutyric acid results in decreased expression of HSPA5 protein]
mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD163 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of CD36 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MARCO mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of NOS2 mRNA]; mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 mRNA]; mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] mono-(2-ethylhexyl)phthalate results in increased secretion of IFNG protein
2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]; 5'-methylthioadenosine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]; anacardic acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]; GW 6471 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IFNL1 mRNA]
mono-(2-ethylhexyl)phthalate results in increased expression of IFNL3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of IFNL3 protein
mono-(2-ethylhexyl)phthalate results in increased expression of IL10 protein mono-(2-ethylhexyl)phthalate results in decreased expression of IL10 protein epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL10 protein]
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL1B mRNA]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein] mono-(2-ethylhexyl)phthalate results in increased expression of IL1B mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of IL1B protein mono-(2-ethylhexyl)phthalate results in increased secretion of IL1B protein
mono-(2-ethylhexyl)phthalate results in increased expression of IL6 mRNA [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of IL6 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of IL6 mRNA]
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of and results in decreased phosphorylation of INSR protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of RAB13 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of RAB8A protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SLC2A4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SRC protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STX4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STXBP3 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of STXBP4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TBC1D4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of SLC2A4 protein; mono-(2-ethylhexyl)phthalate affects the reaction [INS1 protein affects the expression of LNPEP protein]; mono-(2-ethylhexyl)phthalate affects the reaction [INS1 protein affects the expression of SNAP23 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased abundance of Glycogen]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of ARRB2 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of GSK3B protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose] mono-(2-ethylhexyl)phthalate results in increased expression of INS1 mRNA 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein; Akt-I-1,2 compound inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; Cytochalasin B inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]; mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]; Wortmannin inhibits the reaction [mono-(2-ethylhexyl)phthalate promotes the reaction [INS1 protein results in increased uptake of Glucose]]
mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased expression of and results in increased phosphorylation of AKT1 protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [INS protein results in increased phosphorylation of ERN2 protein] [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein; [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of Glycogen]; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of Glycogen]]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of INSL3 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of INSL3 mRNA
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of and results in decreased phosphorylation of INSR protein
mono-(2-ethylhexyl)phthalate results in increased expression of IRF1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of IRF1 protein IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA]; IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of IRS1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of IRS1 protein [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of IRS1 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased phosphorylation of IRS1 protein] [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of IRS1 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of JAG1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of JAG1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of JAG2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of JAG2 protein
[Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of JAK3 promoter; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased expression of JAK3 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of JUNB mRNA 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of JUNB mRNA]
mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased secretion of Testosterone] mono-(2-ethylhexyl)phthalate results in decreased expression of LHB mRNA mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased expression of STAR protein]; mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased secretion of Progesterone]
mono-(2-ethylhexyl)phthalate results in decreased expression of LHCGR mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of LHCGR mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of LIPE mRNA mono-(2-ethylhexyl)phthalate results in increased phosphorylation of LIPE protein [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of LIPE mRNA; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of LIPE protein]
mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK1 protein] mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MAPK1 protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of MAPK1 protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK1 protein] mono-(2-ethylhexyl)phthalate affects the phosphorylation of MAPK1 protein
mono-(2-ethylhexyl)phthalate inhibits the reaction [GDNF protein results in increased phosphorylation of MAPK3 protein] mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MAPK3 protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of MAPK3 protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A] inhibits the reaction [HDAC6 protein affects the phosphorylation of MAPK3 protein] mono-(2-ethylhexyl)phthalate affects the phosphorylation of MAPK3 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of METTL14 protein METTL14 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [METTL14 protein affects the expression of SCARB1 mRNA]
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of MIR141 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MIR184 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of MIR27B mRNA MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein]; MYC protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MIR27B mRNA]
MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein] mono-(2-ethylhexyl)phthalate results in decreased expression of MIR372 mRNA
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] affects the expression of MKI67 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 protein mono-(2-ethylhexyl)phthalate affects the expression of MMP2 mRNA 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 protein]; [SB 3CT compound results in decreased activity of MMP2 protein] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of MMP2 protein]; [SB 3CT compound results in decreased activity of MMP2 protein] which results in decreased susceptibility to mono-(2-ethylhexyl)phthalate; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP2 mRNA]; Fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP2 mRNA]; SB 3CT compound inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of MMP2 protein]
2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]; 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein]; [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased secretion of MMP9 protein; ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of MMP9 mRNA]; Fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA]; mifobate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein] mono-(2-ethylhexyl)phthalate inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of MMP9 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of MMP9 protein
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in decreased expression of MRC1 mRNA
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MTOR protein epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of MTOR protein]
mono-(2-ethylhexyl)phthalate affects the localization of MYC protein [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein]; MYC protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MIR27B mRNA]; tubastatin A inhibits the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of MYC protein] mono-(2-ethylhexyl)phthalate results in increased expression of MYC mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of MYC protein
mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H2 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H3 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NFE2L2 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein 4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein] mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NLRP3 protein
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 protein [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased expression of NOTCH1 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH1 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 protein N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH2 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of NOTCH4 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of NR0B1 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of NR0B1 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of NR0B1 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of NR1H3 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [NCOA1 protein binds to and results in increased activity of NR1H3 protein]
mono-(2-ethylhexyl)phthalate binds to and results in increased activity of NR1I2 protein mono-(2-ethylhexyl)phthalate results in increased activity of NR1I2 protein
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of NR1I3 mRNA; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of NR1I3 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein] mono-(2-ethylhexyl)phthalate results in increased activity of NR1I3 protein alternative form
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] affects the expression of NR2F2 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of NR2F2 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of OCLN protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased localization of OCLN protein
mono-(2-ethylhexyl)phthalate results in increased expression of PCK2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PCK2 protein
mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein mono-(2-ethylhexyl)phthalate results in decreased expression of PCNA protein ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR27B mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein]; MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA mRNA]; MIR372 mRNA inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PCNA protein]
mono-(2-ethylhexyl)phthalate results in increased expression of PDK4 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PDK4 protein
mono-(2-ethylhexyl)phthalate results in increased secretion of PGR protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased secretion of PGR protein]
mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of PIK3R1 protein RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of PIK3R1 protein]
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PINK1 protein]
mono-(2-ethylhexyl)phthalate analog results in increased expression of PLIN1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PLIN1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PLIN1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of PMAIP1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PMAIP1 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of POU5F1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of POU5F1 protein
mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARA protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [PPARA protein binds to NCOR1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to EP300 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to MED1 protein]; mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to PPARGC1A protein] mono-(2-ethylhexyl)phthalate results in decreased expression of PPARA protein mono-(2-ethylhexyl)phthalate binds to PPARA protein mono-(2-ethylhexyl)phthalate results in increased activity of PPARA protein mono-(2-ethylhexyl)phthalate results in increased expression of PPARA mRNA [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of PPARA mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [PPARA protein binds to NCOR1 protein]; PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]; PPARA inhibits the reaction [PPARA gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of FGF21 mRNA]] mono-(2-ethylhexyl)phthalate results in increased expression of PPARA mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PPARA protein
mono-(2-ethylhexyl)phthalate affects the expression of PPARD mRNA; mono-(2-ethylhexyl)phthalate affects the expression of PPARD protein [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARD mRNA mono-(2-ethylhexyl)phthalate results in increased activity of PPARD protein mono-(2-ethylhexyl)phthalate binds to PPARB protein
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; 2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]; [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in decreased methylation of PPARG promoter; mono-(2-ethylhexyl)phthalate binds to and affects the folding of and results in increased activity of PPARG protein; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]; PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]; Rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARG mRNA; mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein mono-(2-ethylhexyl)phthalate affects the expression of PPARG mRNA mono-(2-ethylhexyl)phthalate affects the activity of PPARG protein mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein; mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA mono-(2-ethylhexyl)phthalate binds to PPARG protein mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG protein mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein
mono-(2-ethylhexyl)phthalate promotes the reaction [PPARA protein binds to PPARGC1A protein] mono-(2-ethylhexyl)phthalate results in increased expression of PPARGC1A mRNA
[mono-(2-ethylhexyl)phthalate co-treated with Androgens deficiency] results in increased expression of PTCH1 mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in decreased expression of PTCH1 mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of PTCH1 mRNA
[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN mRNA; [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN protein; [mono-(2-ethylhexyl)phthalate co-treated with bisphenol A co-treated with tubastatin A] results in increased expression of PTEN mRNA; [mono-(2-ethylhexyl)phthalate co-treated with tubastatin A] results in increased expression of PTEN mRNA; HDAC6 protein affects the reaction [[bisphenol A co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of PTEN protein]
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] affects the expression of PTGDS mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PTGDS mRNA
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] affects the expression of PTGES mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of PTGES mRNA
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in decreased expression of PTGS1 mRNA; [mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in decreased expression of PTGS1 protein mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS1 protein
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of PTGS2 protein; Dexamethasone inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA] mono-(2-ethylhexyl)phthalate results in decreased expression of PTGS2 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of PTGS2 protein
RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [[mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein] which results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate inhibits the reaction [INS protein results in increased abundance of Glycogen]]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased activity of INS protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of GSK3B protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of IRS1 protein]; RBP4 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased phosphorylation of PIK3R1 protein] mono-(2-ethylhexyl)phthalate results in increased expression of RBP4 protein
mono-(2-ethylhexyl)phthalate results in increased expression of RELA mRNA mono-(2-ethylhexyl)phthalate affects the expression of RELA protein mono-(2-ethylhexyl)phthalate results in increased expression of RELA protein modified form fulvestrant inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of RELA protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased activity of RELA protein; mono-(2-ethylhexyl)phthalate results in increased phosphorylation of and affects the localization of RELA protein
mono-(2-ethylhexyl)phthalate results in increased phosphorylation of RPS6 protein epigallocatechin gallate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased phosphorylation of RPS6 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 protein mono-(2-ethylhexyl)phthalate results in increased expression of SCARB1 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of SCARB1 mRNA; METTL14 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate affects the reaction [METTL14 protein affects the expression of SCARB1 mRNA]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased methylation of SCARB1 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT1 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT1 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT2 protein
mono-(2-ethylhexyl)phthalate results in increased expression of SIRT3 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT3 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT3 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT4 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT4 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT5 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT5 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT6 protein
mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT7 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SIRT7 protein
[monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of SKP2 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of SLC27A1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of SLC27A1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A1 mRNA mono-(2-ethylhexyl)phthalate results in decreased expression of SLC2A1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of SLC2A4 mRNA [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of SLC2A4 protein; [INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in increased phosphorylation of SLC2A4 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased expression of SLC2A4 protein]
mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 mRNA ferrostatin-1 inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein]; HIF1A gene mutant form inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein] mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of SLC7A11 protein
[mono-(2-ethylhexyl)phthalate co-treated with Androgens deficiency] results in increased expression of SMO mRNA; mono-(2-ethylhexyl)phthalate inhibits the reaction [cyclopamine results in increased expression of SMO mRNA]
mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 protein Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of SOD1 protein] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of SOD1 mRNA
mono-(2-ethylhexyl)phthalate analog results in decreased expression of SP7 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of SP7 mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of SREBF1 mRNA mono-(2-ethylhexyl)phthalate affects the expression of SREBF1 mRNA [Genistein co-treated with mono-(2-ethylhexyl)phthalate] affects the expression of SREBF1 mRNA
mono-(2-ethylhexyl)phthalate results in decreased expression of STAR mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in decreased expression of STAR mRNA] [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of STAR mRNA; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of STAR protein]; Genistein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of STAR mRNA]; mono-(2-ethylhexyl)phthalate inhibits the reaction [LHB protein results in increased expression of STAR protein] mono-(2-ethylhexyl)phthalate results in increased expression of STAR mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of STAR protein mono-(2-ethylhexyl)phthalate results in increased activity of STAR protein mono-(2-ethylhexyl)phthalate affects the expression of STAR
[mono-(2-ethylhexyl)phthalate co-treated with Genistein] results in increased expression of STRA8 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of STRA8 mRNA; mono-(2-ethylhexyl)phthalate results in increased expression of STRA8 protein
[INS1 protein co-treated with mono-(2-ethylhexyl)phthalate] results in decreased expression of TBC1D4 protein; mono-(2-ethylhexyl)phthalate inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein 2-chloro-5-nitrobenzanilide inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]; mifobate inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]; PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP2 mRNA; mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP2 protein ESR1 protein affects the reaction [mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 mRNA] mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 mRNA; mono-(2-ethylhexyl)phthalate affects the expression of TIMP2 protein Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TIMP2 protein]
mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]; mono-(2-ethylhexyl)phthalate results in decreased expression of and results in decreased localization of TJP1 protein
mono-(2-ethylhexyl)phthalate results in increased secretion of TNF protein mono-(2-ethylhexyl)phthalate promotes the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TNF mRNA] mono-(2-ethylhexyl)phthalate results in increased expression of TNF mRNA
Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TRP53 protein] mono-(2-ethylhexyl)phthalate results in increased expression of TP53 protein TP53 protein results in decreased susceptibility to mono-(2-ethylhexyl)phthalate gingerol inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TP53 protein]; mono-(2-ethylhexyl)phthalate results in increased phosphorylation of and results in increased expression of TP53 protein; Selenomethionine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein]; Sodium Selenite inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of TP53 protein]
[Genistein co-treated with mono-(2-ethylhexyl)phthalate] results in increased expression of TSPO mRNA mono-(2-ethylhexyl)phthalate results in increased expression of TSPO mRNA
mono-(2-ethylhexyl)phthalate results in increased expression of WNT4 mRNA mono-(2-ethylhexyl)phthalate promotes the reaction [Tretinoin results in increased expression of WNT4 mRNA]
4-phenylbutyric acid inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; Acetylcysteine inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in increased localization of XBP1 protein alternative form; Toyocamycin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of XBP1 protein alternative form]
mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 mRNA]; IRF1 protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of YAP1 protein]; LATS1 protein inhibits the reaction [mono-(2-ethylhexyl)phthalate results in increased stability of YAP1 protein]; mono-(2-ethylhexyl)phthalate results in increased expression of and results in decreased phosphorylation of and results in increased activity of and affects the localization of and results in increased stability of YAP1 protein
mono-(2-ethylhexyl)phthalate results in increased expression of ZBTB16 mRNA mono-(2-ethylhexyl)phthalate results in increased expression of PLZF protein